Article Figures & Data
Figures
- Figure 1.
Optimal size and power for two-armed balanced fixed sample clinical trial according to Bayesian decision analysis (BDA) in which the expected loss of false positives and negatives is jointly minimized. The left figure displays the expected cost to patients as a function of the false positive rate (the BDA optimal value minimizes this expected cost), and the right figure displays the true positive rate (or power) as a function of the false positive rate. For an interactive version of these graphs, see the Supplemental Material.
Additional Files
Supplemental Data
In this issue
Incorporating Patient Preferences via Bayesian Decision Analysis
Jump to section
More in this TOC Section
Cited By...
- Using Patient Preference Information to Inform Regulatory Decision Making: An Opportunity to Spur Patient-Centered Innovation in Kidney Replacement Therapy Devices
- Overview of Various Components of the Science of Patient Input: Advancing the Use of Patient-Reported, Real-World Evidence for Medical Device Evaluation of Innovative Products for the Treatment of Kidney Failure Using Strategically Coordinated Registry Networks
- Legitimization and Incorporation of Patient Preferences: The Arrow that Hit the Achilles Heel of Status Quo Kidney Care